Rappel de Device Recall Symbiq One Channel Infuser

Selon U.S. Food and Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à United States qui a été fabriqué par Hospira Inc..

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    63993
  • Classe de risque de l'événement
    Class 2
  • Numéro de l'événement
    Z-0353-2017
  • Date de mise en oeuvre de l'événement
    2013-02-05
  • Statut de l'événement
    Terminated
  • Pays de l'événement
  • Date de fin de l'événement
    2016-12-15
  • Source de l'événement
    USFDA
  • URL de la source de l'événement
  • Notes / Alertes
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Notes supplémentaires dans les données
    Pump, infusion - Product Code FRN
  • Cause
    Hospira has received reports of malfunction s205 backup battery failure alarms in symbiq v3.13 pumps. this issue to an incorrect installation of components on some of the power supply controller (psc) boards distributed prior to september 2012. on pumps where incorrect installation of components has occurred, the backup battery power discharges and subsequently, the battery cannot be charged. because of the battery depletion, or lack of charge, a visual and audible warning alarm, s205, is displayed. an s205 alarm is intended to notify the customer that the coin call battery, powering the backup buzzer, may need to be charged or replaced.
  • Action
    Hospira sent an Urgent Field Device Correction letter dated Feburay 5, 2013, to all affected customers. Hospira has implemented a correction to the manufacturing process to address this issue. Symbiq v3.13 pumps that have been shipped from Hospira since September 2012 and pumps that were upgraded to v3.13 in the Field after September 2012 are not impacted by this issue. If you are unsure of when you were shipped Symbiq v3.13 pumps or when your devices were upgraded, contact Hospira. Please complete the attached reply form and return it via fax number or e-mail address on the form, even if you do not currently have the impacted infuser. lease contact Stericycle at 1-866-201-9072 (M-F, Bam - 5pm EST) to obtain additional copies of the reply form. If you have further distributed these devices, please notify your accounts who may have received these infusers from you and ask them to contact Stericycle at 1-866-201-9072 (M-F, 8am- 5pm EST) to receive a reply form.

Device

  • Modèle / numéro de série
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide Distribution - US (nationwide) and Canada
  • Description du dispositif
    Symbiq One Channel Infuser; an Rx medical device infusion pump used to administer I.V. fluids. List number 16026. Note that Hospira retired this pump June 30, 2015. || The Hospira Symbiq Infusion System is intended for the delivery of fluids, solutions, drugs, agents, nutritionals, electrolytes, blood, and blood products via parenteral, enteral, intravenous, intra-arterial, subcutaneous, epidural, or irrigation routes of administration.
  • Manufacturer

Manufacturer

  • Adresse du fabricant
    Hospira Inc., 275 N Field Dr, Lake Forest IL 60045-2579
  • Société-mère du fabricant (2017)
  • Source
    USFDA